[
  {
    "ts": null,
    "headline": "Patient Monitoring Devices Research Report 2025: A Global $55+ Billion Market by 2030, Dominated by GE HealthCare, F. Hoffmann-La Roche, Koninklijke Philips, Medtronic, and Abbott",
    "summary": "Key opportunities in the global patient monitoring devices market include expanding use of miniaturized multi-sensing devices and adoption due to stringent regulations, enhanced self-management of chronic diseases, and growth potential in emerging regions. Sustainability and ESG practices also offer competitive advantages. Patient Monitoring Devices Market Patient Monitoring Devices Market Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The \"Patient Monitoring Devices: Global Markets\" report has been",
    "url": "https://finnhub.io/api/news?id=7e3eee5b9d8d0b2305ab44dae2028d27dfccb1eb7327e4dbe081dc638787fc38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760971620,
      "headline": "Patient Monitoring Devices Research Report 2025: A Global $55+ Billion Market by 2030, Dominated by GE HealthCare, F. Hoffmann-La Roche, Koninklijke Philips, Medtronic, and Abbott",
      "id": 137174216,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key opportunities in the global patient monitoring devices market include expanding use of miniaturized multi-sensing devices and adoption due to stringent regulations, enhanced self-management of chronic diseases, and growth potential in emerging regions. Sustainability and ESG practices also offer competitive advantages. Patient Monitoring Devices Market Patient Monitoring Devices Market Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The \"Patient Monitoring Devices: Global Markets\" report has been",
      "url": "https://finnhub.io/api/news?id=7e3eee5b9d8d0b2305ab44dae2028d27dfccb1eb7327e4dbe081dc638787fc38"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains",
    "summary": "Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.",
    "url": "https://finnhub.io/api/news?id=94e8b23eff28a76a2edbdc8ac5374b3ff63a30a48cdceff6bcc5a6b064f5ac43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760967120,
      "headline": "Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains",
      "id": 137174217,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.",
      "url": "https://finnhub.io/api/news?id=94e8b23eff28a76a2edbdc8ac5374b3ff63a30a48cdceff6bcc5a6b064f5ac43"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For October",
    "summary": "Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.",
    "url": "https://finnhub.io/api/news?id=7e5e4d81e7f7bbf4ace2094dc8b479304205e7043756c5390b7cef95e12da826",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760955567,
      "headline": "IXJ: Healthcare Sector Dashboard For October",
      "id": 137167977,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409850701/image_1409850701.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.",
      "url": "https://finnhub.io/api/news?id=7e5e4d81e7f7bbf4ace2094dc8b479304205e7043756c5390b7cef95e12da826"
    }
  }
]